Neogene is a biotechnology company that develops and commercializes T cell-based therapies for the treatment of cancer. Neogene was founded in 2018. Neogene's headquarters is located in New York, New York, USA 10022. It has raised 125.0M in 2 rounds. ...
There have been no acquisitions found related to Neogene
Recent investment data cannot be found related to Neogene